Cancer–neuronal crosstalk and the startups working to silence it
Elie Dolgin • Feb 07, 2020
Investors back ‘cancer neuroscience’ outfits as the field breaks out from academia.
Continue reading here.
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
FDA panel’s green light on glaucoma wearable device offers hope in sight.